+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Supply and Logistics Market for Pharma 2023-2033

  • PDF Icon

    Report

  • 258 Pages
  • September 2023
  • Region: Global
  • Visiongain
  • ID: 5806107
Description Jump to:
Overall world revenue for Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 in terms of value will surpass US$13 billion in 2023. The author predicts strong revenue growth through to 2033. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Clinical Trial Supply and Logistics for Pharma Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Digitization, Personalized Medicine, and Globalization Reshaping Clinical Trials Supply Logistics Landscape

The landscape of clinical trial supply logistics in the pharmaceutical industry is undergoing a significant transformation. The trends towards digitization, personalized medicine, and globalization are reshaping how companies approach the management and distribution of investigational products. While regulatory compliance and patient-centricity remain paramount, the industry is presented with opportunities to leverage advanced technologies for more agile and efficient supply chain operations. Overcoming challenges associated with supply chain complexity, unforeseen events, and cost pressures will be critical for companies seeking to navigate this evolving landscape successfully. By embracing these trends and seizing the associated opportunities, pharmaceutical companies can optimize their clinical trial supply chains to deliver innovative therapies to patients more efficiently than ever before.

3D Printing and On-Demand Manufacturing

The advent of 3D printing technology opens up a new frontier in clinical trial supply logistics. It offers the potential to revolutionize the manufacturing and production of investigational products. 3D printing allows for on-demand, localized production of certain medical devices, dosage forms, and even personalized treatments.

This opportunity is particularly significant for trials involving specialized or niche patient populations. Rather than relying on centralized manufacturing facilities and extensive lead times, pharmaceutical companies can use 3D printing to produce customized investigational products closer to the trial sites. This not only reduces transportation and logistics complexities but also enables a more patient-centric approach to clinical trials.

Furthermore, 3D printing can facilitate rapid prototyping and iteration of medical devices, allowing for the development of more effective and tailored solutions. This technology empowers researchers to quickly adapt and refine their products based on real-world feedback from clinical trials, ultimately leading to more innovative and impactful therapies.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the clinical trial supply and logistics for pharma market evolving?
  • What is driving and restraining the clinical trial supply and logistics for pharma market?
  • How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the clinical trial supply and logistics for pharma projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of
clinical trial supply and logistics for pharma projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?
  • Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:

  • Our 258-page report provides 107 tables and 123 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the clinical trial supply and logistics for pharma market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, this new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type

  • CTS Manufacturing
  • CTS Logistics & Distribution
  • CT Supply Chain Management
  • CTS Packaging & Storage

Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Post Launch
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

  • Almac Group
  • Bilcare Limited
  • Biocair
  • Capsugel
  • Catalent, Inc.
  • Eurofins Scientific
  • FedEx
  • ICON plc
  • Intertek Group plc
  • KERRY LOGISTICS NETWORK LIMITED
  • Kuehne+Nagel
  • Marken (A UPS Company)
  • Mayne Pharma Group Limited
  • Movianto
  • Parexel International (MA) Corporation
  • PCI Pharma Services (PCI)
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • Yourway

How will the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 report help you?

In summary, the 250+ page report provides you with the following knowledge:
  • Revenue forecasts to 2033 for Clinical Trial Supply and Logistics for Pharma Market 2023 to 2033, with forecasts for type and phase, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 22 key national markets - See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 19 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how the work could benefit your research, analyses, and decisions. The study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Move Towards Decentralized/Virtual Trials
3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
3.2.1.3 Growing Clinical Trials Volume
3.2.2 Market Restraining Factors
3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
3.2.2.2 Man-made or Natural Disruption in Transportation
3.2.2.3 High Financial Cost
3.2.3 Market Opportunities
3.2.3.1 AI and Machine Learning are Evolving with More Data
3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
3.2.3.3 Big Companies are driving the Market
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
4.4 CTS Manufacturing
4.4.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 CTS Logistics & Distribution
4.5.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 CT Supply Chain Management
4.6.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 CTS Packaging & Storage
4.7.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2023 & 2033 (%)
5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase
5.1 Key Findings
5.2 Phase Segment: Market Attractiveness Index
5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
5.4 Preclinical
5.4.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Phase I
5.5.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Phase II
5.6.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Phase III
5.7.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Phase IV
5.8.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Post Launch
5.9.1 Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2023 & 2033 (%)
6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region
6.1 Key Findings
6.2 Regional Market Size Estimation and Forecast
7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis
7.1 Key Findings
7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis
8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
8.1 Key Findings
8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
8.13 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
9.1 Key Findings
9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
10.1 Key Findings
10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
10.9 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
11.1 Key Findings
11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2023, 2028 & 2033 (US$ Billion)
11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
12 Company Profiles
12.1 Catalent, Inc.
12.1.1 Company Snapshot
12.1.2 Company Overview
12.1.3 Financial Analysis
12.1.3.1 Net Revenue, 2018-2022
12.1.3.2 Regional Market Shares, 2022
12.1.4 Product Benchmarking
12.1.5 Strategic Outlook
12.2 Thermo Fisher Scientific Inc.
12.2.1 Company Snapshot
12.2.2 Company Overview
12.2.3 Financial Analysis
12.2.3.1 Net Revenue, 2018-2022
12.2.3.2 R&D, 2015-2022
12.2.3.3 Regional Market Shares, 2022
12.2.4 Product Benchmarking
12.2.5 Strategic Outlook
12.2.6 Strategic Outlook
12.3 ICON plc
12.3.1 Company Snapshot
12.3.2 Company Overview
12.3.3 Financial Analysis
12.3.3.1 Revenue, 2018-2022
12.3.3.2 Regional Market Shares, 2022
12.3.4 Product Benchmarking
12.3.5 Strategic Outlook
12.4 Eurofins Scientific
12.4.1 Company Snapshot
12.4.2 Company Overview
12.4.3 Financial Analysis
12.4.3.1 Net Revenue, 2018-2022
12.4.3.2 Regional Market Shares, 2022
12.4.4 Services Offered
12.4.5 Strategic Outlook
12.5 FedEx
12.5.1 Company Snapshot
12.5.2 Company Overview
12.5.3 Financial Analysis
12.5.3.1 Net Revenue, 2015-2022
12.5.3.2 Regional Market Shares, 2022
12.5.4 Product Benchmarking
12.5.5 Strategic Outlook
12.6 United Parcel Service, Inc.
12.6.1 Company Snapshot
12.6.2 Company Overview
12.6.3 Financial Analysis
12.6.3.1 Net Revenue, 2018-2022
12.6.4 Product Benchmarking
12.7 KERRY LOGISTICS NETWORK LIMITED
12.7.1 Company Snapshot
12.7.2 Company Overview
12.7.3 Financial Analysis
12.7.3.1 Net Revenue, 2017-2021
12.7.3.2 Regional Market Shares, 2022
12.7.4 Product Benchmarking
12.8 Kuehne+Nagel
12.8.1 Company Snapshot
12.8.2 Company Overview
12.8.3 Financial Analysis
12.8.3.1 Net Revenue, 2018-2022
12.8.3.2 Regional Market Shares, 2022
12.8.4 Product Benchmarking
12.8.5 Strategic Outlook
12.9 Bilcare Limited
12.9.1 Company Snapshot
12.9.2 Company Overview
12.9.3 Financial Analysis
12.9.3.1 Net Revenue, 2018-2022
12.9.3.2 Regional Market Shares, 2022
12.9.4 Product Benchmarking
12.10 Mayne Pharma Group Limited
12.10.1 Company Snapshot
12.10.2 Company Overview
12.10.3 Financial Analysis
12.10.3.1 Net Revenue, 2018-2022
12.10.3.2 Regional Market Shares, 2022
12.10.4 Product Benchmarking
12.10.5 Strategic Outlook
12.11 Intertek Group plc
12.11.1 Company Snapshot
12.11.2 Company Overview
12.11.3 Financial Analysis
12.11.3.1 Net Revenue, 2017-2021
12.11.4 Product Benchmarking
12.11.5 Strategic Outlook
12.12 Almac Group
12.12.1 Company Snapshot
12.12.2 Company Overview
12.12.3 Product Benchmarking
12.12.4 Strategic Outlook
12.13 Parexel International (MA) Corporation
12.13.1 Company Snapshot
12.13.2 Company Overview
12.13.3 Product Benchmarking
12.13.4 Strategic Outlook
12.14 Biocair
12.14.1 Company Snapshot
12.14.2 Company Overview
12.14.3 Product Benchmarking
12.14.4 Strategic Outlook
12.15 Marken (A UPS Company)
12.15.1 Company Snapshot
12.15.2 Company Overview
12.15.3 Product Benchmarking
12.15.4 Strategic Outlook
12.16 PCI Pharma Services (PCI)
12.16.1 Company Snapshot
12.16.2 Company Overview
12.16.3 Product Benchmarking
12.16.4 Strategic Outlook
12.17 Capsugel
12.17.1 Company Snapshot
12.17.2 Company Overview
12.17.3 Product Benchmarking
12.17.4 Strategic Outlook
12.18 Movianto
12.18.1 Company Snapshot
12.18.2 Company Overview
12.18.3 Product Benchmarking
12.19 Yourway
12.19.1 Company Snapshot
12.19.2 Company Overview
12.19.3 Product Benchmarking
13 Conclusion and Recommendations
13.1 Concluding Remarks
13.2 Recommendations for Market Players
List of Tables
Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2023 & 2033 (US$ billion, CAGR %)
Table 2 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Clinical Trial Supply and Logistics Market for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 7 CTS Manufacturing Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 8 CTS Logistics & Distribution Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 9 CT Supply Chain Management Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 10 CTS Packaging & Storage Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 11 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 12 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 13 Phase I Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 14 Phase II Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 15 Phase III Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 16 Phase IV Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 17 Post Launch Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 18 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 19 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 20 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 21 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 22 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 23 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 24 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 25 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 26 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 27 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 28 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 29 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 30 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 31 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 32 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 33 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 34 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 35 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 36 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 37 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 38 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 39 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 40 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 41 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 42 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 43 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 44 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 45 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 46 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 47 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 48 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 49 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 50 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 51 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 52 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 53 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 54 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR%, CAGR%)
Table 55 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 56 Catalent, Inc.: Product Benchmarking
Table 57 Catalent, Inc.: Strategic Outlook
Table 58 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 59 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 60 Thermo Fisher Scientific Inc.: Recent Developments
Table 61 UDG Healthcare Plc: Recent Developments
Table 62 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 63 ICON plc: Product Benchmarking
Table 64 ICON plc: Recent Developments
Table 65 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 66 Eurofins Scientific: Services Offered
Table 67 Eurofins Scientific: Strategic Outlook
Table 68 FedEx: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 FedEx: Product Benchmarking
Table 70 FedEx: Strategic Outlook
Table 71 United Parcel Service, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 United Parcel Service, Inc.: Product Benchmarking
Table 73 KERRY LOGISTICS NETWORK LIMITED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 KERRY LOGISTICS NETWORK LIMITED: Product Benchmarking
Table 75 Kuehne+Nagel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 76 Kuehne+Nagel: Product Benchmarking
Table 77 Kuehne+Nagel: Strategic Outlook
Table 78 Bilcare Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Bilcare Limited: Product Benchmarking
Table 80 Mayne Pharma Group Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Mayne Pharma Group Limited: Product Benchmarking
Table 82 Mayne Pharma Group Limited: Recent Developments
Table 83 Intertek Group plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 Intertek Group plc: Product Benchmarking
Table 85 Intertek Group plc: Recent Developments
Table 86 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 87 Almac Group: Product Benchmarking
Table 88 Almac Group: Recent Developments
Table 89 Parexel International (MA) Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 90 Parexel International (MA) Corporation: Product Benchmarking
Table 91 Parexel International (MA) Corporation: Recent Developments
Table 92 Biocair: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Biocair: Product Benchmarking
Table 94 Biocair: Strategic Outlook
Table 95 Marken (A UPS Company): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Marken (A UPS Company): Product Benchmarking
Table 97 Marken (A UPS Company): Strategic Outlook
Table 98 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 PCI Pharma Services (PCI): Product Benchmarking
Table 100 PCI Pharma Services (PCI): Recent Developments
Table 101 Capsugel: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Capsugel: Product Benchmarking
Table 103 Capsugel: Recent Developments
Table 104 Movianto: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Movianto: Product Benchmarking
Table 106 Yourway: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Yourway: Product Benchmarking
List of Figures
Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
Figure 4 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
Figure 5 Global Clinical Trials Supply and Logistics Market: Market Dynamics
Figure 6 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “V” Shaped Recovery
Figure 7 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “U” Shaped Recovery
Figure 8 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “W” Shaped Recovery
Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Billion, AGR %): “L” Shaped Recovery
Figure 10 Clinical Trial Supply and Logistics for Pharma Market: Porter’s Five Forces Analysis
Figure 11 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
Figure 12 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 13 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 14 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023, 2028, 2033 (%)
Figure 15 CTS Manufacturing Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 16 CTS Manufacturing Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 CTS Logistics & Distribution Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 18 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 CT Supply Chain Management Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 20 CT Supply Chain Management Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 CTS Packaging & Storage Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 22 CTS Packaging & Storage Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 24 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 25 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023, 2028, 2033 (%)
Figure 26 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 27 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Phase I Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 29 Phase I Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Phase II Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 31 Phase II Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Phase III Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 33 Phase III Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Phase IV Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 35 Phase IV Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Post Launch Segment Market Forecast by Region, 2023-2033 (US$ Billion, AGR %)
Figure 37 Post Launch Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 39 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 40 Clinical Trial Supply and Logistics for Pharma Market by Region, 2023-2033 (US$ Mn)
Figure 41 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 42 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 43 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 44 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 45 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 46 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 47 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 48 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 49 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 50 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 51 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 52 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 53 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 54 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 55 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 56 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 57 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 58 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 59 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 60 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 61 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 62 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 63 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 64 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 65 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 66 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 67 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 68 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 69 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 70 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 71 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 72 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 73 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 74 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 75 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 76 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 77 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 78 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 79 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 80 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 81 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 82 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 83 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 84 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 85 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 86 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 87 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 88 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 89 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 90 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 91 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 92 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 93 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2023, 2028 & 2033 (US$ Billion)
Figure 94 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2023-2033 (US$ billion)
Figure 95 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2023 & 2033 (%)
Figure 96 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2023-2033 (US$ Billion, AGR %)
Figure 97 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2023 & 2033 (%)
Figure 98 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2023-2033 (US$ Billion, AGR %)
Figure 99 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 100 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 101 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 102 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2023-2033 (US$ Billion, AGR %)
Figure 103 Catalent, Inc.: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 104 Catalent, Inc.: Regional Market Shares, 2022
Figure 105 Thermo Fisher Scientific Inc: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 106 Thermo Fisher Scientific Inc: R&D, 2018-2022 (US$ Million, AGR%)
Figure 107 Thermo Fisher Scientific Inc: Regional Market Shares, 2022
Figure 108 ICON plc: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 109 ICON plc: Regional Market Shares, 2022
Figure 110 Eurofins Scientific: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 111 Eurofins Scientific: Regional Market Shares, 2022
Figure 112 FedEx: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 113 FedEx: Regional Market Shares, 2022
Figure 114 United Parcel Service, Inc.: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 115 KERRY LOGISTICS NETWORK LIMITED: Net Revenue, 2017-2021 (US$million, AGR %)
Figure 116 KERRY LOGISTICS NETWORK LIMITED: Regional Market Shares, 2022
Figure 117 Kuehne+Nagel: Net Revenue, 2018-2022 (US$ million, AGR%)
Figure 118 Kuehne+Nagel: Regional Market Shares, 2022
Figure 119 Bilcare Limited: Net Revenue, 2018-2022 (US$million, AGR %)
Figure 120 Bilcare Limited: Regional Market Shares, 2022
Figure 121 Mayne Pharma Group Limited: Net Revenue, 2018-2022 (US$ Million, AGR %)
Figure 122 Mayne Pharma Group Limited: Regional Market Shares, 2022
Figure 123 Intertek Group plc: Net Revenue, 2017-2021 (US$ Million, AGR %)

Companies Mentioned

  • Almac Group
  • Bilcare Limited
  • Biocair
  • Capsugel
  • Catalent, Inc.
  • Eurofins Scientific
  • FedEx
  • ICON plc
  • Intertek Group plc
  • KERRY LOGISTICS NETWORK LIMITED
  • Kuehne+Nagel
  • Marken (A UPS Company)
  • Mayne Pharma Group Limited
  • Movianto
  • Parexel International (MA) Corporation
  • PCI Pharma Services (PCI)
  • Thermo Fisher Scientific Inc.
  • United Parcel Service, Inc.
  • Yourway
  • Concordance Healthcare Solutions LLC
  • Owens & Minor, Inc.
  • Palantir Technologies Inc
  • Pharmaniaga Berhad (Pharmaniaga)
  • Slope
  • SYMPLR
  • Association of British Pharmaceutical Industry (ABPI)
  • Association for Supply Chain Management (ASCM)
  • Central Drugs Standard Control Organization (CDSCO)
  • Department of Health and Family Welfare
  • Development and Reform Commission (NDRC)
  • European Commission
  • European Medicines Agency (EMA)
  • Food and Drug Administration (US FDA)
  • Indian Drug Manufacturer's Association (IDMA)
  • International Society of Pharmaceutical Engineering (IPSE)
  • Korea Food and Drug Administration (KFDA)
  • Korea Pharmaceutical Manufacturer's Association (KPMA)
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • Medicines Manufacturing Industry Partnership (MMIP)
  • Ministry of Health (MOH)
  • Ministry of Health, Labor and Welfare (MHLW)
  • Ministry of Industry and Information Technology (MIIT)
  • Pharmaceutical and Medical Devices Agency (PMDA)
  • World Health Organization (WHO)

Related Topics

Related Reports

Global Clinical Trials Market Report and Forecast 2023-2031 - Product Image

Global Clinical Trials Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Clinical Trials Market in US 2023-2027 - Product Image

Clinical Trials Market in US 2023-2027

  • Report
  • 148 Pages
  • United States
From
Global Clinical Trials Connect 2024 (London, United Kingdom - May 28-29, 2024) - Product Image

Global Clinical Trials Connect 2024 (London, United Kingdom - May 28-29, 2024)

  • Conference
  • 2 Days
  • Global
Clinical Trial Supplies Market Report 2024-2034 - Product Image

Clinical Trial Supplies Market Report 2024-2034

  • Report
  • 373 Pages
  • Global
From
Clinical Trial Supply and Logistics Global Market Report 2024 - Product Image

Clinical Trial Supply and Logistics Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.